Eli Lilly and Co- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Eli Lilly and Co 公司

公司简介

公司代码LLY

公司名称Eli Lilly and Co

上市日期Jul 09, 1970

成立日期1901

CEOMr. David A. (Dave) Ricks

员工数量47000

证券类型Ordinary Share

年结日Jul 09

公司地址Lilly Corporate Ctr

城市INDIANAPOLIS

上市交易所NYSE Consolidated

国家United States of America

邮编46285

电话13172762000

网址https://www.lilly.com/

公司代码LLY

上市日期Jul 09, 1970

成立日期1901

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Daniel M. Skovronsky, M.D., Ph.D.

Executive Vice President, Chief Scientific Officer and President - Lilly Research Laboratories and Lilly Immunology

206.66K

+9.98%

Ms. Anne E. White

Executive Vice President, President - Lilly Neuroscience

74.20K

+13.18%

Mr. J. Erik Fyrwald

Independent Director

72.23K

+0.02%

Mr. Patrik Jonsson

Executive Vice President, President of Lilly Diabetes and Obesity and President of Lilly USA

54.12K

+20.12%

Mr. Edgardo Hernandez

Executive Vice President, President - Manufacturing Operations

39.74K

+4.13%

Ms. Anat Hakim

Executive Vice President, General Counsel, Secretary

28.83K

+82.76%

Mr. Ilya Yuffa

Executive Vice President, President of Lilly International

28.76K

+45.24%

Ms. Johna L. Norton

Executive Vice President - Global Quality

25.78K

-21.49%

Dr. Katherine Baicker, Ph.D.

Independent Director

23.01K

+1.33%

Mr. Diogo Rau

Executive Vice President, Chief Information and Digital Officer

19.71K

+77.63%

名称

名称/职务

职务

持股

持股变动

Dr. Daniel M. Skovronsky, M.D., Ph.D.

Executive Vice President, Chief Scientific Officer and President - Lilly Research Laboratories and Lilly Immunology

206.66K

+9.98%

Ms. Anne E. White

Executive Vice President, President - Lilly Neuroscience

74.20K

+13.18%

Mr. J. Erik Fyrwald

Independent Director

72.23K

+0.02%

Mr. Patrik Jonsson

Executive Vice President, President of Lilly Diabetes and Obesity and President of Lilly USA

54.12K

+20.12%

Mr. Edgardo Hernandez

Executive Vice President, President - Manufacturing Operations

39.74K

+4.13%

Ms. Anat Hakim

Executive Vice President, General Counsel, Secretary

28.83K

+82.76%

收入明细

单位: USD更新时间: 3月5日周三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Diabetes-Mounjaro

11.54B

25.62%

Oncology-Verzenio

5.30B

11.78%

Diabetes-Trulicity

5.25B

11.66%

Diabetes-Zepbound

4.92B

10.93%

Diabetes-Jardiance

3.34B

7.41%

Other

14.67B

32.58%

地区USD

名称

营收

占比

U.S.

30.37B

67.43%

Europe

6.92B

15.36%

Other foreign countries

4.27B

9.48%

Japan

1.81B

4.02%

China

1.66B

3.68%

业务

地区

业务USD

名称

营收

占比

Diabetes-Mounjaro

11.54B

25.62%

Oncology-Verzenio

5.30B

11.78%

Diabetes-Trulicity

5.25B

11.66%

Diabetes-Zepbound

4.92B

10.93%

Diabetes-Jardiance

3.34B

7.41%

Other

14.67B

32.58%

股东统计

更新时间: 2月21日周五

持股股东

股东类型

持股股东

股东统计

占比

Lilly Endowment, Inc.

10.12%

The Vanguard Group, Inc.

7.79%

PNC Investments LLC

5.38%

BlackRock Institutional Trust Company, N.A.

4.33%

State Street Global Advisors (US)

3.61%

Other

68.73%

持股股东

股东统计

占比

Lilly Endowment, Inc.

10.12%

The Vanguard Group, Inc.

7.79%

PNC Investments LLC

5.38%

BlackRock Institutional Trust Company, N.A.

4.33%

State Street Global Advisors (US)

3.61%

Other

68.73%

股东类型

股东统计

占比

Investment Advisor

37.98%

Investment Advisor/Hedge Fund

25.88%

Foundation

10.24%

Research Firm

1.87%

Pension Fund

1.87%

Bank and Trust

1.78%

Insurance Company

1.42%

Sovereign Wealth Fund

1.24%

Hedge Fund

1.09%

Other

16.58%

机构持股

更新时间: 2月20日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q1

5438

794.89M

83.72%

-769.21K

2024Q4

5528

795.43M

83.87%

+627.51K

2024Q3

5177

793.56M

83.49%

-5.02M

2024Q2

5068

795.79M

83.72%

-2.01M

2024Q1

4916

795.03M

83.62%

-6.22M

2023Q4

4670

799.46M

84.21%

-2.36M

2023Q3

4354

800.21M

84.30%

-1.19M

2023Q2

4197

799.48M

84.22%

-4.31M

2023Q1

4061

801.35M

84.15%

-9.39M

2022Q4

3985

805.63M

84.79%

-7.50M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Lilly Endowment, Inc.

96.89M

10.2%

--

Dec 31, 2024

The Vanguard Group, Inc.

73.89M

7.79%

+486.78K

+0.66%

Dec 31, 2024

PNC Investments LLC

51.08M

5.38%

-49.68K

-0.09%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

41.11M

4.33%

+29.74K

+0.07%

Dec 31, 2024

State Street Global Advisors (US)

34.31M

3.61%

+461.69K

+1.36%

Dec 31, 2024

Fidelity Management & Research Company LLC

29.35M

3.09%

-2.41M

-7.60%

Dec 31, 2024

T. Rowe Price Associates, Inc.

19.73M

2.08%

-77.25K

-0.39%

Dec 31, 2024

Capital World Investors

19.55M

2.06%

-803.43K

-3.94%

Dec 31, 2024

Geode Capital Management, L.L.C.

17.38M

1.83%

+291.87K

+1.70%

Dec 31, 2024

PRIMECAP Management Company

16.75M

1.76%

-933.85K

-5.27%

Dec 31, 2024

持股ETF

更新时间: 3月5日周三

机构名称

占比

Defiance Daily Target 2X Long LLY ETF

191.91%

iShares U.S. Pharmaceuticals ETF

23.51%

Roundhill GLP-1 & Weight Loss ETF

15.46%

Amplify Weight Loss Drug & Treatment ETF

15.08%

Future Fund Active ETF

13.55%

Health Care Select Sector SPDR Fund

12.83%

VanEck Pharmaceutical ETF

12.59%

Proshares Ultra Health Care

11.59%

iShares U.S. Healthcare ETF

11.34%

Fidelity MSCI Health Care Index ETF

10.33%

Defiance Daily Target 2X Long LLY ETF

占比191.91%

iShares U.S. Pharmaceuticals ETF

占比23.51%

Roundhill GLP-1 & Weight Loss ETF

占比15.46%

Amplify Weight Loss Drug & Treatment ETF

占比15.08%

Future Fund Active ETF

占比13.55%

Health Care Select Sector SPDR Fund

占比12.83%

VanEck Pharmaceutical ETF

占比12.59%

Proshares Ultra Health Care

占比11.59%

iShares U.S. Healthcare ETF

占比11.34%

Fidelity MSCI Health Care Index ETF

占比10.33%

分红派息

近5年累计派现 18.05B 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Dec 09, 2024

LLY.NB Interim Cash Dividend of gross USD 1.5 paid on Mar 10, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 10, 2025

Feb 14, 2025

Oct 28, 2024

LLY.NB Final Cash Dividend of gross USD 1.3 paid on Dec 10, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Dec 10, 2024

Nov 15, 2024

Jun 24, 2024

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Sep 10, 2024 going ex on Aug 15, 2024

Aug 15, 2024

Sep 10, 2024

Aug 15, 2024

May 06, 2024

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Jun 10, 2024 going ex on May 15, 2024

May 16, 2024

Jun 10, 2024

May 15, 2024

Dec 08, 2023

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Mar 08, 2024 going ex on Feb 14, 2024

Feb 15, 2024

Mar 08, 2024

Feb 14, 2024

Nov 01, 2023

LLY.NB Final Cash Dividend of gross USD 1.13 paid on Dec 08, 2023 going ex on Nov 14, 2023

Nov 15, 2023

Dec 08, 2023

Nov 14, 2023

Jun 26, 2023

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Sep 08, 2023 going ex on Aug 14, 2023

Aug 15, 2023

Sep 08, 2023

Aug 14, 2023

May 01, 2023

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Jun 09, 2023 going ex on May 12, 2023

May 15, 2023

Jun 09, 2023

May 12, 2023

Dec 12, 2022

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 10, 2023 going ex on Feb 14, 2023

Feb 15, 2023

Mar 10, 2023

Feb 14, 2023

Oct 17, 2022

LLY.NB Final Cash Dividend of gross USD 0.98 paid on Dec 09, 2022 going ex on Nov 14, 2022

Nov 15, 2022

Dec 09, 2022

Nov 14, 2022

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Eli Lilly and Co

929.720USD

Eli Lilly and Co

929.720

概览

公司